Health
Estrogen Patch Shortage Continues to Impact Pharmaceutical Industry
Pharmaceutical companies are struggling to meet the increased demand for estrogen patches in the U.S., leading to ongoing shortages despite federal policy changes and regulatory oversight.
Coverage timeline — 1 article
The Hill
The pharmaceutical industry is warning that estrogen patches continue to be in shortage in the U.S. as manufacturers struggle to keep up with increased demand linked to federal policy changes issued earlier this year, even as regulators have yet to recognize a lack in supply. Manufacturers first re
2026-08-21 10:00 UTC